On April 9, 2021, the National Medical Products Administration (NMPA) promulgated the “Cosmetic Efficacy Claims Evaluation Standards”, which will be implemented on May 1, 2021. Following hereby “The Standards”. This Standards serves as an important regulatory basis for the evaluation of cosmetic efficacy claims in China after the implementation of the “Cosmetics Supervision and Administration Regulations (CSAR).”
The CosmeticsBridge expert sorted out the six key points of the “Cosmetics Efficacy Claim Evaluation Specification” to help you quickly understand the new regulations.
1. Submit Basis Summary of Efficacy Claims
Except for the efficacy claims that only have physical effects, the Standards requires cosmetic registrants or filing persons to upload a basis summary of product efficacy claims on a special website designated by the NMPA. This provision applies to all cosmetics that are marketed in the Chinese market. Therefore, cosmetics that have been registered or filed/notified before May 1, 2021, need to supplement the basis summary before May 1, 2023.Tags: CSAR Efficacy Claims